Page 423 - شرور شركات الأدوية

‫ﻣﻼﺣﻈﺎت‬

Better Patients, Better Decisions: Envisioning Health Care 2020. 1st ed. MIT
Press; 2011.

(36) Malenka DJ, Baron JA, Johansen S, Wahrenberger JW, Ross JM.
The framing effect of relative and absolute risk. J Gen Intern Med. 1993
Oct;8(10):543–8.

(37) Bucher HC, Weinbacher M, Gyr K. Influence of method of report-
ing study results on decision of physicians to prescribe drugs to lower
cholesterol concentration. BMJ. 1994 Sep 24;309(6957):761–4.

(38) Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: under-
standing results of clinical trials and systematic reviews. BMJ. 1995 Oct
21;311(7012):1056–9.

(39) Express.co.uk New wonder heart pill that may save millions [Inter-
net]. [cited 2012 Feb 12]. Available from: http://www.express.co.uk/posts/
view/70343.

(40) Drug could save thousands from heart attacks—Science—The
Guardian [Internet]. [cited 2012 Feb 12]. Available from: http://www
.guardian.co.uk/science/2008/nov/10/drugs-medical-research.

(41) Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and Inter-
pretation of Randomized Controlled Trials With Statistically Nonsignifi-
cant Results for Primary Outcomes. JAMA. 2010 May 26;303(20):2058–64.

(42) Alasbali, T. et al., 2009. Discrepancy between results and abstract
conclusions in industry—vs nonindustry-funded studies comparing top-
ical prostaglandins. American Journal of Ophthalmology, 147(1), pp. 33–
38.e2.

(43) Jørgensen AW, Hilden J, Gøtzsche PC. Cochrane reviews compared
with industry supported meta-analyses and other meta-analyses of the
same drugs: systematic review. BMJ. 2006 Oct 14;333(7572):782.

423